Antiproliferative effects of withanolides from Withania adpressa

Therapie

Volumn 64, Issue 2, 2009, Pages 121-127

  Abdeljebbar, Lalla Hasna ^a,b   Benjouad, Abdelaziz ^a   Morjani, Hamid ^c   Merghoub, Nawal ^a   Haddar, Saoussan El ^a   Humam, Munir ^d   Christen, Philippe ^d   Hostettmann, Kurt ^d   Bekkouche, Khalid ^b   Amzazi, Saaïd ^a  

^a FACULTÉ DES SCIENCES   (Morocco)

^b FACULTÉ DES SCIENCES SEMLALIA   (Morocco)

^c UFR Sciences Exactes et Naturelles   (France)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Apoptosis; Cytotoxicity; DNA fragmentation; Withania adpressa; Withanolides

Indexed keywords

14ALPHA,15ALPHA,17BETA,20BETA TETRAHYDROXY 1 OXO WITHA 2,5,24 TRIENOLIDE; ANTINEOPLASTIC AGENT; NITROBLUE TETRAZOLIUM; UNCLASSIFIED DRUG; WITHANOLIDE; WITHANOLIDE F; WITHANOLIDE J;

ANGIOSPERM; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOASSAY; CANCER CELL CULTURE; CELL STRAIN HT29; CYTOTOXICITY; DNA FRAGMENTATION; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; FRACTIONATION; HEP 2 CELL; HUMAN; HUMAN CELL; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; REVIEW; VERO CELL; WITHANIA; WITHANIA ADPRESSA;

EID: 68649092293     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie/2009015     Document Type: Article

References (22)

1. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol 2005; 100: 72-79
2. Cragg GM, Newman DJ, Stringuer, SY. Natural product extracts of plant and marine origin having antileukemia potential. The NCI experience. J Nat Prod 2005; 69: 488-498
3. Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 2003; 66: 1022-1037
4. Bellakhdar J. La pharmacopée marocaine traditionnelle. Paris : Ibis Press,1997
5. Mathur R, Gupta SK, Singh N, et al. Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis. J Ethopharmacol 2006; 105: 336-341
6. Jayaprakasam B, Zhang y, Seeram NP, et al. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Science 2003; 74: 125-132
7. Mulabagal V, Subbaraju GV, Rao CV, et al. Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-Kappa-B, cyclooxygenase and tumor cell proliferation. Phytother Res 2009; 23: 987-992
8. Mathur R, Gupta SR, Singh N, et al. Evaluation of the effect of withania somnifera root extracts on cell cycle and angiogenesis. J Ethnopharmacol 2006; 105: 336-341
9. Widodo N, Tagaki Y, Shrestha BG, et al. Selective killing of cancer cells by leaf extract of Ashwagandha: Components, activity and pathway analyses. Cancer Lett 2008; 262(1): 37-47
10. Sethi PN, Thiagarajan AR, Subramanian SS. Studies on the anti- inflammatory and anti-arthritic activity of withaferin A. Indian J Pharmacol 1970; 2: 165
11. Budhiraja RD, Sudhir S. Review of biological activity of withanolides. Journal Sci Ind Res 1987; 46 : 488-499
12. Devi PU.Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Indian J Exp Biol 1986; 34: 927-932
13. Abdeljebbar LH, Human M, Christen P, et al. Withanolides from Withania adpressa. Helv Chim Acta 2007; 90: 346-352
14. ATCC Cultures and Products: http://www.lgcstandards-atcc.org/ ATCCCulturesandProducts/tabid/979/Default.aspx
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63 (Pubitemid 14203433)
16. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89: 271-277 (Pubitemid 16080782)
17. Kazuyo S, Maliko S, Tadakazu A, et al. UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G2 checkpoint abrogation. Int J Cancer 2000; 85(5): 703-709
18. Sasaki M, Okamura M, Ideo A, et al. Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin. Anticancer Res 2006; 26(5A): 3373-3380 (Pubitemid 44701511)
19. Gong JS, Channy P, Chan YK, et al. Mitomycin-C induces the apoptosis of human tenon's capsule fibroblast by activation of c-Jun N-terminal kinase 1 and caspase-3 protease. Invest Ophth Vis Sci 2005; 46: 3545-3552
20. Suffness M, Pezzuto JM. Assays related to cancer drug discovery. In: K. Hostettmann (Ed). Methods in Plant Biochemistry 1990: Assays for Bioactivity, Vol.6. Academic Press, London, pp. 71-133
21. Ichikawa H, Takada Y, Shishodia S, et al. Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-κB (NF-κB) activation and NF-κB-regulated gene expression. Mol Cancer Ther 2006; 5: 1434-1445 (Pubitemid 44070479)
22. Senthil V, Ramadevi S, Venkatakrishnan V, et al. Withanolide induces apoptosis in HL-60 leukemia cells via mitochondria mediated cytochrome C release and caspase activation. Chem Biol Interact 2007; 167: 19-30 (Pubitemid 46431216)